BOOST Pharma ApS

CVRCVR number41120495

Core data

Name	BOOST Pharma ApS
Address	Nordre Fasanvej 215, 2000, Frederiksberg
Founded	Jan 20, 2020
Employees (CVR)	5
Locations (P-units)	1 View locations
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Name	BOOST Pharma ApS
Address	Nordre Fasanvej 215, 2000, Frederiksberg
Founded	Jan 20, 2020

Employees (CVR)	5
Locations (P-units)	1 View locations
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of BOOST Pharma ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.

Free account

Description

Selskabets hovedaktivitet består i at forske, udvikle og tilvejebringe lægemidler. Selskabet udvikler en ny celleterapibehandling for Osteogenesis Imperfecta (OI), hvor det primære aktiv er BT-101. Denne behandling er baseret på et proprietært celleprodukt, der inkluderer mesenkymale stamceller med høje knogledannende egenskaber. I 2025 har ledelsen etableret et svensk selskab, Boost Pharma AB. I forbindelse hermed er de hidtidige aktionærers kapitalandele i Boost Pharma ApS overdraget til det svenske moderselskab og besiddes herefter indirekte gennem ejerskab i Boost Pharma AB. Boost Pharma AB ejer 100 % af kapitalandelene i Boost Pharma ApS. Den nye ejerstruktur blev gennemført i efteråret 2025.

Financials

View detailed financials

Company financials

Reporting period	2025DKK	2024Locked	2023Locked	2022Locked	2021Locked	20 Jan - 31 Dec 2020Locked347 days / short period
Gross profit	-7,557,572	Locked	Locked	Locked	Locked	Locked
Operating profit	-9,579,634	Locked	Locked	Locked	Locked	Locked
Profit before tax	-10,826,750	Locked	Locked	Locked	Locked	Locked
Net income	-9,243,488	Locked	Locked	Locked	Locked	Locked
Total assets	7,206,920	Locked	Locked	Locked	Locked	Locked
Equity	-11,850,535	Locked	Locked	Locked	Locked	Locked
Avg. employees	2	Locked	Locked	Locked	Locked	Locked
2020–2025 Unlock financial history

Datapublica Risk Score

Locked

Assesses the risk of financial distress using the company’s accounts, history, and connections.

Company score

0 · Low100 · High

What goes into the assessment

Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details

Standard: Score and risk bandPro: Also a detailed explanation of the factors

See plans Learn about Risk Score

Contact

No contact details have been registered for this company.

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Person	Roles	Titles
Hans Thalsgård Schambye	Roles Management	TitlesADM. DIR.

Auditor

Audit firm	Auditor	Role	From
Baker Tilly Denmark	AuditorMuqadas Rasheed	Rolestatsautoriseret revisor	FromJun 24, 2026

Legal owners

View ownership diagram

Owner	Ownership	Voting rights	From
BOOST Pharma AB🇸🇪 Foreign legal entity	Ownership100 %	Voting rights100 %	FromOct 30, 2025

Ultimate owners